ON-DEMAND WEBINARS

Explore an overview of the regulatory framework and expectations, and see the benefit of a comprehensive approach to CCI tailored for mAbs and complex modalities such as fusion proteins or bioconjugates.

‘Brick dust’ compounds require additional steps if spray drying is to yield a commercially attractive process. Explore three enabling technologies designed to improve drug solubility in organic solvents for spray drying.

Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

We discuss three enabling technologies designed to improve drug solubility in organic solvents for spray drying and define the advantages and risks of each technology.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

Tom von Gunden, Chief Editor & Community Director, Drug Delivery Leader

Tom ensures that Drug Delivery Leader provides you with indispensable resources for staying current on the industry’s most innovative thinking. Get in touch today!


Fran DeGrazio, Executive Editor - Drug Delivery Leader & Frankly Fran

In her new column, Fran offers keen industry insights exclusively on Drug Delivery Leader.

FRANKLY FRAN

  • Regulations and standards for drug delivery systems and packaging are ever evolving and expanding, making it harder and more costly for older products to meet them. In this article, Fran DeGrazio explains why it is imperative that pharma companies consider new product adoption. 

FREE EBOOK: COMBINATION PRODUCTS

Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.